Acuitas Therapeutics

Acuitas is the premier LNP (lipid nanoparticle) technology provider, enabling our partners to advance new therapeutics to address unmet clinical needs. We have developed a broad IP portfolio focussed on the use of LNP technology for nucleic acid therapeutics. This portfolio primarily encompasses novel compositions of matter but also includes novel uses of nucleic acids therapeutics.

Our mission is
· To provide our partners with the best LNP delivery technology for nucleic acid therapeutics
· To support our partners to rapidly advance new therapeutics to address unmet medical needs
· To continually innovate to maintain and strengthen our LNP technological lead

Acuitas partners locally and globally with companies, academic institutes and other organizations to improve human health.